PASITHEA THERAPEUTICS CORP. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
PASITHEA THERAPEUTICS CORP. (KTTA) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $24.30 million as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2024-03-29
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $24.30M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $14.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2023-12-31 | $24.30M 10-K · filed 2024-03-29 |
| 2022-12-31 | $14.50M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |